Medicines

  1. Takhzyro (lanadelumab)
    Takhzyro (lanadelumab)
    by Shire Pharmaceuticals
    for Hereditary angioedema (HAE)
    €17,768.40
  2. Cablivi (caplacizumab)
    Cablivi (caplacizumab)
    by Ablynx NV
    for
    €6,792.00
  3. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €10,885.55
  4. Kalydeco (ivacaftor)
    Kalydeco (ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €11,800.00
  5. Symkevi (tezacaftor/ivacaftor)
    Symkevi (tezacaftor/ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €7,200.00
  6. Vitrakvi (larotrectinib)
    Vitrakvi (larotrectinib)
    by Bayer
    for Solid Tumor
    €14,800.00
  7. Vizimpro (dacomitinib)
    Vizimpro (dacomitinib)
    by Pfizer Limited
    for Lung Cancer
    €19,680.00
  8. Copiktra (duvelisib)
    Copiktra (duvelisib)
    by Verastem Inc.
    for Leukemia, Lymphoma
    €16,800.00
  9. Erleada (apalutamide)
    Erleada (apalutamide)
    by Janssen Biotech
    for Prostate Cancer
    €4,225.86
View as Grid List

Items 10-18 of 76

per page
Set Descending Direction